... risk/increased number of fractures? Population: Adults Interventions: HIV infection Comparisons: Reference population Outcomes: Relative or absolute fracture risk 52. ...

... a partnership with the Australian government to provide HIV testing and antiretroviral drugs in China. China has also been involved in several important HIV-vaccine research efforts. These include a collaboration among ...

... other gastrointestinal symptoms in patients being treated for HIV or AIDs with antiretroviral drugs. In March, Jaguar applied for Emergency Use ...

... the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on ...

... the area of care for people who have HIV disease, there is a standard of care. AZT, antiretroviral, starts at a certain level; prophylaxis for various ...

... antivirals comprise seven Other Drug Groups, Antivirals, 20% antiretrovirals (drugs that are used primarily in 28% the treatment of HIV), two hepatitis C agents, and one other type ...

... asymptomatic patients with underlying immune suppression, such as HIV-1 infection, who generally would not be treated for asymptomatic CMV infection. Before adding the investigational drug to other approved therapies, the sponsor should assess the potential for drug- ...

... high launch prices. The introduction of the additional therapies allowed certain insurers to negotiate lower prices, but did not necessarily lower the initial launch prices. 82 See for example, T. L. ...

... OLDER AMERICANS, 2006 TO 2020 21 day of therapy. The drug products that met this definition were considered "specialty drugs" and all other prescription drugs were considered "regular," "traditional," or "nonspecialty" drugs. Throughout this report, references to the market basket of drugs refer to ...

... some are generic) average cost per day of ... of the previous criteria (e.g., HIV drugs). Previous Rx Price Watch reports found that ...